3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
ClearOne, Inc. entered into a Loan Agreement dated October 14, 2026, with First Finance Ltd., effective October 7, 2026, under which First Finance agreed to lend the company $200,000. The company expects to use the proceeds for general working capital, and the filing says repayment timing is still to be determined and mutually agreed in writing.
Principal amount of $200,000; the loan bears no interest, including during an event of default.
Repayment date is to be determined and mutually agreed in writing by ClearOne and First Finance.
The company may prepay at any time without notice, bonus or penalty.
Events of default include failure to pay when due, subject to a five-business-day cure period, and bankruptcy or liquidation; governing law is Nevada.
Exascale Labs agreed to sell 12 NVIDIA HGX B300 GPU servers, with network equipment, deployment and 36 months of IT operation services, to a U.S. subsidiary of Taiwan's Sunonwealth Electric Machine Industry for a total contract value of $8,208,000 before import duties and taxes. The filing does not state the effect on the company's revenue or profit, and delivery depends on a 30% down payment, chip manufacturer approval and export and import authorizations.
Total contract value is US$8,208,000, exclusive of import duties and taxes.
Buyer is Sunon Inc., a California subsidiary of Sunonwealth Electric Machine Industry Co., Ltd. (TWSE: 2421).
Payment: 30% down payment within three days of the buyer's purchase order, with the remaining 70% due five business days after shipment-readiness notice.
Agreement dated October 8, 2026, entered October 9, 2026; the filing was dated October 15, 2026.
TriplePoint Venture Growth BDC Corp. declared a regular quarterly distribution of $0.23 per share for the fourth quarter, payable December 30, 2026 to stockholders of record as of December 16, 2026. The company said a previously announced $0.06 per share supplemental distribution will be paid on the same dates, and that it will release third quarter 2026 financial results after market close on November 4, 2026. The filing contains no new financial results.
Regular distribution: $0.23 per share, payable December 30, 2026, record date December 16, 2026
Supplemental distribution: $0.06 per share, previously announced August 5, 2026, same payment and record dates
Third quarter 2026 results to be released after market close on Wednesday, November 4, 2026, with a conference call at 5:00 p.m. Eastern Time
Tron Inc. entered a sales agreement with Clear Street LLC allowing it to sell common stock from time to time through an at-the-market offering. The company is not obligated to sell any shares, and sales would be made under an existing Form S-3 registration statement, so the filing signals potential future share issuance that could dilute existing holders.
Agreement dated October 14, 2026, with Clear Street LLC, covering common stock with par value $0.0001 per share.
Clear Street receives a commission of up to 3% of aggregate gross proceeds from sales as agent.
Neither the company nor Clear Street must sell shares; either party may terminate on ten days' prior written notice.
Shares would be offered under Form S-3 registration statement File No. 333-288986; the filing does not state a dollar amount or number of shares.
Star Equity Holdings furnished an October 14, 2026 investor presentation under Regulation FD, with figures as of June 30, 2026, on its website and as Exhibit 99.1. The deck shows Q2 2026 trailing-twelve-month pro forma revenue of $223.9 million and Adj. EBITDA of $5.9 million, and sets a long-term goal of about $40 million in Adj. EBITDA by 2030. The filing is an informational presentation and reports no new earnings or guidance change.
2030 Adj. EBITDA goal of about $40 million, split by segment: Building Solutions ~$15.0 million, Business Services ~$25.0 million, Energy Services ~$7.0 million, Investments ~$1.0 million
As of June 30, 2026: cash $8.9 million, debt less cash (net debt) $5.2 million; about $11 million of shares repurchased since 2019
Verastem agreed to sell 30,937,500 common shares at $8.00 each, plus pre-funded warrants for up to 312,503 shares, through underwriters led by Jefferies and Guggenheim. The company expects net proceeds of about $234.7 million, with closing expected on or about October 15, 2026. The sale adds a substantial number of shares to the outstanding count, which dilutes existing holders.
30,937,500 common shares offered at $8.00 each, before underwriting discounts and commissions
Pre-funded warrants for up to 312,503 shares offered at $7.9999 each, with a $0.0001 exercise price
Expected net proceeds of approximately $234.7 million, after underwriting discounts and estimated expenses
Offering made under a shelf registration effective August 15, 2025; closing expected on or about October 15, 2026
Lawson Products, a wholly owned subsidiary of Distribution Solutions Group, agreed on October 12, 2026 to acquire GradeEight Holdings for about $145 million, subject to adjustments, funded by borrowings under its $400 million revolving credit facility and available cash. The deal is a significant acquisition, and the filing also references a separate July 15, 2026 merger agreement under which the company would become private and leave Nasdaq, with its CEO's affiliates owning about 78.5% of shares.
Purchase price is approximately $145 million, with no financing condition
GradeEight generates approximately $110 million in annual sales and is expected to close in the fourth quarter of 2026
Separate July 15, 2026 merger agreement with entities affiliated with CEO J. Bryan King, who with LKCM Headwater owns about 78.5% of shares
Completion of that merger would delist the common stock from Nasdaq and requires stockholder approval
Rezolute said the open-label Phase 3 upLIFT study of ersodetug in tumor hyperinsulinism is fully enrolled, with 16 participants, and topline data are expected in mid-December 2026. The filing contains no new efficacy data, and the company said it will continue its expanded access program.
Study is fully enrolled with approximately 16 participants; topline data expected mid-December 2026
Earlier in 2026, 7 of the first 8 participants met the primary endpoint responder criterion
The eighth participant died one week after enrollment from cancer progression and is counted as a non-responder
Statistical significance requires a response rate of at least 56% (95% CI of 30-80%) for 16 participants
Rent the Runway's subscription period for its previously announced $15 million rights offering expired at 5:00 p.m. Eastern Time on October 14, 2026. Rights not exercised by that deadline have expired and can no longer be exercised, and the filing gives no figures on how many rights were exercised or how much capital was raised.
Subscription period for the $15 million rights offering expired at 5:00 p.m. Eastern Time on October 14, 2026
Rights not exercised by the expiration date are no longer exercisable
The filing does not state the amount of capital raised or the number of rights exercised
Andersen Group Inc. appointed Daniel DePaoli and Peter Coscia, both longtime senior executives, to its Board of Directors effective October 13, 2026. The Board size increases from 8 to 10 directors, and the company says the appointments add operational expertise as it pursues global growth.
Daniel DePaoli and Peter Coscia appointed to the Board, effective October 13, 2026
Board size increased from 8 directors to 10
DePaoli has held senior leadership roles at Andersen since 2002; Coscia has held leadership roles there since 2002
Filing does not disclose financial results or compensation terms for the new directors
Neuraxis's board declared a third-quarter 2026 dividend on its Series B Preferred Stock, payable in common stock rather than cash. About 81,339 common shares are expected to be issued, priced at $2.38 per share, with the payment due October 30, 2026 to holders of record as of October 26, 2026.
Dividend paid in common stock, based on accrued unpaid dividends from July 1, 2026 through the record date divided by $2.38
About 81,339 common shares expected to be issued
Fractional shares paid in cash at $2.38 per whole share
Payable October 30, 2026 to holders of record as of October 26, 2026
Alight posted confidential lender presentation materials on its website, titled "Alight, Inc. Supplemental Information," after discussing a possible refinancing or extension of its May 1, 2017 credit agreement. The company said it has elected not to actively pursue that transaction and has no definitive agreement, and it reaffirmed its 2026 business outlook. The materials are dated to April through June 2026 and should not be relied on for investment decisions.
Alight made its Cleansing Materials available on its website on October 14, 2026, and they will remain available through December 31, 2026.
The company has elected not to actively pursue a potential refinancing or extension of its credit agreement dated May 1, 2017, and no definitive agreement has been reached.
Alight reaffirmed its previously disclosed full year 2026 business outlook, and the Cleansing Materials' projections do not change it.
Nathan's Famous said it is voluntarily supplementing its definitive proxy statement for the proposed $102.00-per-share merger with Smithfield Foods, after two stockholder lawsuits and fifteen demand letters challenged the proxy's disclosures. The company and its board deny the claims, but say the supplements aim to moot the disclosure claims and reduce litigation costs and risks before the October 23, 2026 special meeting of stockholders.
Two lawsuits were filed September 30, 2026, in the Supreme Court of the State of New York against the company and its board, and seek to enjoin the merger.
Purported stockholders delivered fifteen demand letters and two Section 220 books-and-records demands under Delaware law.
The supplemental disclosures cover executive retention discussions with the buyer and Jefferies LLC's selected companies analysis.
The special meeting of stockholders is scheduled for October 23, 2026; the merger consideration is $102.00 per share.
Five Below entered into a Third Amendment to its Credit Agreement on October 14, 2026, with Wells Fargo as agent. The amendment extends the maturity date from September 16, 2027 to October 14, 2031, and doubles the senior secured asset-based revolving credit facility from $225 million to $450 million. For shareholders, the filing shows expanded borrowing capacity and a longer maturity, but the filing does not describe any drawn amount or the reason for the change.
Maturity date extended from September 16, 2027 to October 14, 2031
Revolving credit facility increased from $225 million to $450 million
Letter of credit subline increased from $20 million to $50 million
Amendment filed as Exhibit 10.1; signed by CFO Daniel J. Sullivan
Innovative Industrial Properties agreed on October 8, 2026 to sell 2,000,000 shares of 9.25% Series B Cumulative Redeemable Preferred Stock at $25.00 per share, with expected net proceeds of about $48.4 million before expenses and before any exercise of the 300,000-share underwriter option. The offering is expected to close on or about October 19, 2026, and the new preferred stock ranks ahead of common shares on distributions, so common holders would face restrictions on payouts if preferred distributions are not declared.
Underwritten offering of 2,000,000 Series B preferred shares at $25.00 per share, with Stifel, Nicolaus & Company as representative
Expected net proceeds of about $48.4 million, before estimated expenses and excluding the 300,000-share option
Offering expected to close on or about October 19, 2026, subject to customary closing conditions
Articles Supplementary filed October 13, 2026 with a $25.00 per share liquidation preference
Comtech said CFO Michael Bondi will leave after he files the first-quarter fiscal 2027 Form 10-Q, and Richard Nyren, now Executive Vice President, Finance, will become CFO at that point. The company tied the changes to the anticipated closing of the sale of most of its Satellite and Space Communications business to an affiliate of Gilat Satellite Networks, and it also named Amy Rothstein-Hovey as General Counsel. The filing says Bondi's departure is amicable and not the result of any disagreement on accounting, financial reporting or controls.
Bondi remains CFO through the filing of the first-quarter fiscal 2027 Form 10-Q, currently anticipated by December 10, 2026
Nyren, age 56, has an annualized base salary of $425,000, a 75% target bonus and a $100,000 sign-on bonus
Bondi receives a lump sum severance of 2.0 times his base salary plus target bonus, plus $500,000 and $300,000 cash payments in place of certain equity awards
Rothstein-Hovey joined as General Counsel on October 1, 2026, succeeding Don Walther, who remains through the S&S closing
Invesco Mortgage Capital Inc. declared a $0.12 per share cash dividend for October 2026, payable November 16, 2026, and released preliminary unaudited September 30, 2026 data. Estimated book value per common share was $6.74, and the debt-to-equity ratio was 7.6x; the filing does not compare these figures with prior periods, and the data is not audited.
Monthly dividend of $0.12 per share; ex-dividend and record date October 26, 2026; payable November 16, 2026
Estimated book value per common share of $6.74 as of September 30, 2026
Total investment portfolio including TBAs of $8.0 billion; total repurchase agreement borrowings of $6.8 billion
Debt-to-equity ratio 7.6x; economic debt-to-equity ratio 8.3x; unrestricted cash and unencumbered investments of $401.3 million
On October 8, 2026, KB Home's compensation committee approved performance-based restricted stock unit awards to CEO Robert V. McGibney, Jeffrey T. Mezger and Brian J. Woram. The awards vest based on three-year cumulative earnings per share, average return on invested capital and relative revenue growth over December 1, 2026 to November 30, 2029, and this routine compensation disclosure does not change reported results.
Enliven Therapeutics appointed Kristine Ball as a Class II director and Audit Committee member, effective October 14, 2026, expanding the board from seven to eight directors. The company says the appointment comes as it prepares to start the pivotal Phase 3 ENABLE-2 trial of relcobatinib before year-end 2026, a routine governance change with no financial results disclosed.
Kristine Ball appointed Class II director, term expiring at the 2028 annual meeting, and Audit Committee member, effective October 14, 2026
Ball receives $45,000 per year as an outside director and $10,000 per year for Audit Committee service
Initial stock option grant with a grant date fair value of approximately $650,000, vesting monthly over 36 months
Company plans to initiate the Phase 3 ENABLE-2 trial of relcobatinib before year-end 2026
Mattel amended the September 29, 2026 offer letter with Roger Lynch, its Chief Executive Officer, setting his start date as October 12, 2026 and moving the timing of his initial equity awards to that date. The amendment also raises his change-in-control severance multiplier to 2.99 times from two times for terminations on or before December 31, 2028, and adds an excise tax make-whole payment for changes of control on or before that date, which shareholders may view as added cost tied to the CEO's pay package.
Start date set as October 12, 2026; make-whole, inducement and 2026 annual long-term awards now granted on that date rather than the last trading day of the month
Awards total 461,538 make-whole RSUs, 461,538 inducement PSUs and 461,538 annual PSUs at target plus 307,692 annual RSUs
Change-in-control cash severance multiplier raised to 2.99 times from two times for qualifying terminations through December 31, 2028
Excise tax make-whole provision applies to a change of control on or before December 31, 2028; the filing says the amendment followed recent external developments
Corvex, Inc. entered an At-the-Market Sales Agreement with Chardan Capital Markets LLC on October 14, 2026, allowing it to sell common stock from time to time. The company pays a 2.5% commission on gross proceeds and intends to use net proceeds for working capital and general corporate purposes. The company has no obligation to sell any shares and may suspend sales at any time, so the filing sets up potential future dilution rather than an immediate share issuance.
Chardan Capital Markets LLC acts as sales agent under the agreement dated October 14, 2026
Corvex pays a 2.5% commission on aggregate gross proceeds from share sales
Legal fees reimbursable up to $75,000 at signing, $10,000 per quarter thereafter, and $30,000 per program refresh
Shares are sold under a Form S-3 shelf registration declared effective September 16, 2026
Riot Platforms entered a custody agreement with BitGo Bank & Trust, which will hold its digital assets and cash, replacing NYDIG Trust Company as custodian. The filing describes segregated accounts, a monthly fee based on average custodied asset value, and a one-year renewable term, but it does not disclose the dollar amount of assets or fees.
Agreement dated October 7, 2026, amended October 14, 2026; NYDIG Trust's custodial agreement terminates when assets transfer to BitGo Bank & Trust
Assets to be held in segregated accounts, with the company retaining title; the company pays a monthly fee based on average asset value
Initial one-year term with automatic renewal; either party may give 60 days' notice of non-renewal; company may terminate early on 14 days' notice with no termination fee
Future Vision II Acquisition Corp. issued a $65,000 non-interest-bearing promissory note to its sponsor, Hwei Super Speed Co., Ltd., to fund a one-month extension of its deadline to complete a business combination, from October 13, 2026 to November 13, 2026. The company states there is no assurance it will complete a business combination by November 13, 2026, and that it continues to pursue its merger with MicroTouch Technology Inc.
Promissory note principal of $65,000 issued October 12, 2026, to sponsor Hwei Super Speed Co., Ltd.
Note is forgiven if no business combination is completed; otherwise it may convert into units at $10.00 per unit at the sponsor's option
Business combination deadline extended from October 13, 2026 to November 13, 2026
Company reminds market participants that Rights do not convert into Ordinary Shares before a business combination closes
Silo Pharma signed an asset purchase agreement on October 13, 2026, to acquire certain software and related intellectual property from Larry King. The company paid by issuing 150,000 shares of common stock, which are locked up for up to 12 months. The filing does not state the value of the assets or the share price, so the deal's size relative to Silo's business cannot be assessed from this filing.
Agreement dated October 13, 2026, with Larry King as seller
Consideration: 150,000 shares of common stock, par value $0.0001 per share
Shares locked up until the earliest of 12 months, a Change in Control, or company consent
Seller indemnifies the company for misrepresentation, third-party infringement and gross negligence, fraud or intentional misconduct
Lisata Therapeutics' board increased its size from seven to eight members and appointed Jeffrey Farrow, currently CFO and Chief Strategy Officer of Tarsus Pharmaceuticals, to fill the new seat effective October 13, 2026. Mr. Farrow also joined the Audit Committee, and the board determined he is independent under Nasdaq listing rules.
Appointed effective October 13, 2026 as a Class III director, with an initial term expiring at the 2028 annual meeting
Joins the Audit Committee; the board determined he is independent under Nasdaq Capital Market listing rules
Has been CFO and Chief Strategy Officer of Tarsus Pharmaceuticals since April 2023 and previously served as CFO of Global Blood Therapeutics until its acquisition by Pfizer in December 2022
LGI Homes entered into a Seventh Amendment to its credit agreement with Wells Fargo as administrative agent and several lenders on October 9, 2026. The amendment extends the maturity of certain lenders' commitments to October 9, 2030, and provides for aggregate revolving commitments of approximately $1.166 billion, including a $175 million incremental facility.
Amendment dated October 9, 2026, with Wells Fargo Bank, National Association as administrative agent
Commitments of $855 million, or 73.3%, mature October 9, 2030; 18.4% mature April 28, 2029; 8.3% mature April 28, 2028
Aggregate revolving commitments of approximately $1.166 billion, including a $175 million incremental facility
Amendment also modifies borrowing base values and certain financial and other covenants
Jackson Financial's board elected Donald C. Templin as a new independent director on October 12, 2026, filling the vacancy left by Gregory Durant's resignation earlier this year. He also joined the Audit and Compensation Committees, and the filing says he qualifies as an audit committee financial expert, which matters to shareholders because it adds audit oversight experience to the board.
Board elected Templin on October 12, 2026, for a term ending at the 2027 Annual Meeting of Shareholders
Templin fills the vacancy from Gregory Durant's resignation and joins the Audit and Compensation Committees
Non-employee director pay is an annual cash retainer of $125,000 and an annual equity grant valued at $185,000
Templin is former Executive Vice President and Chief Financial Officer of Voya Financial and previously a certified public accountant at PricewaterhouseCoopers LLP
Costco's Board of Directors declared a quarterly cash dividend of $1.47 per share on October 14, 2026. The dividend is payable November 13, 2026, to shareholders of record at the close of business on October 30, 2026, so it sets the timing for cash payments to existing holders.
Flyte Aviation announced a multi-year partnership under which it is named the Official Private Aviation Partner of the Philadelphia 76ers. The filing furnishes the October 14, 2026 press release and includes no financial results, deal value, or payment terms, so the financial effect on shareholders is not quantified.
Multi-year partnership with the Philadelphia 76ers announced October 14, 2026
Flyte named the Official Private Aviation Partner of the team
Planned activities include digital and social media, premium hospitality, fan engagement, and a "Halftime Flyte Challenge" giving selected fans a chance to win a private flight
Filing does not disclose contract value or financial terms
Pine Tree Acquisition Corp., a Cayman Islands blank check company, closed its initial public offering of 10,000,000 units at $10.00 per unit on October 7, 2026, raising $100 million in gross proceeds. The full $100 million was deposited in a trust account for public shareholders, and the company has until October 7, 2027 to complete an initial business combination. The filing states that the company has not yet selected a target business.
IPO of 10,000,000 units at $10.00 each, $100,000,000 gross proceeds, closed October 7, 2026
Each unit includes one Class A ordinary share and one right to receive three-fourths of one share upon a business combination
Private placement of 140,000 units to sponsors Pine Tree Sponsor Group, LLC and North Penn, LLC for $1,400,000
$100,000,000 placed in trust account; deadline to complete a business combination is October 7, 2027
Green Dot Corporation disclosed that General Counsel Amy Pugh notified the company on October 8, 2026, that she will resign to pursue another professional opportunity. Her resignation takes effect November 2, 2026. The filing does not name a successor or describe any compensation arrangements.
Amy Pugh notified Green Dot of her decision to resign as General Counsel on October 8, 2026.
Her resignation is effective November 2, 2026.
She is leaving to pursue another professional opportunity; the filing does not name a successor.
Yext's board on October 11, 2026 approved a nonstatutory stock option for CEO Michael Walrath covering 11,000,000 shares at a $7.00 exercise price, a premium to the $6.93 close on October 9, 2026. The option vests only if the stock hits one of 14 escalating price targets over up to ten years, and it requires stockholder approval within twelve months. The grant is significant because it aligns the CEO's potential pay with large share price gains, but its value depends entirely on those gains being achieved.
Option covers 11,000,000 shares at $7.00 per share, with a ten-year term
Vesting is tied to 14 tranches with target prices from $21.00 to $88.08 per share
Option is subject to stockholder approval within twelve months and is granted outside the 2016 Equity Incentive Plan
Exhibit 10.1, the Stand-Alone Stock Option Agreement dated October 11, 2026, is filed with the report
Beneficient disclosed an amendment, effective October 7, 2026, to a letter agreement with HH-BDH, LLC, a lender tied to a board member. The amendment moves the deadline for a $1,000,000 cash payment, originally due five business days after September 30, 2026, to March 31, 2027. The amount is small, but the filing shows the payment timing has changed and that the counterparty is linked to a director.
Borrower agreed to pay HH-BDH $1,000,000 in cash no later than five business days after September 30, 2026.
Effective October 7, 2026, the parties amended the letter agreement to extend the payment deadline to March 31, 2027.
HH-BDH's managing member's parent is controlled by Mack Hicks, who is a member of Beneficient's board of directors.
The letter agreement relates to remaining interest and fees under a Credit and Guaranty Agreement dated October 19, 2023.
At its October 12, 2026 annual meeting, All In FutureTech stockholders approved raising the share authorization under the company's 2019 Equity Incentive Plan from 627,218 to 1,911,281 shares. They also approved issuing 707,730 shares to President Yangyang Li under a May 2, 2026 agreement. The increase expands the pool of shares available for equity awards, and the Li issuance adds shares to outstanding stock.
Equity plan authorized shares rise by 1,284,063, from 627,218 to 1,911,281.
707,730 shares to be issued to President Yangyang Li under the Share Issuance and Reimbursement Agreement dated May 2, 2026.
Li share issuance vote under the NASDAQ standard: 1,570,120 for, 25,174 against, 220,610 abstentions.
All six director nominees were elected, and ZH CPA, LLC was ratified as auditor for fiscal year ending December 31, 2026.
CervoMed Inc. filed an 8-K furnishing an investor presentation covering its business, clinical studies, development plans and financial position, posted on its website. The filing contains no financial results, guidance or new figures, so shareholders have no new numbers to assess from the filing itself.
Presentation posted on cervomed.com under Investors – Events and Presentations.
Company may use the presentation at investor conferences and meetings, in whole or in part.
Filing is furnished under Item 7.01, not deemed filed under Section 18 of the Exchange Act.
Filing is signed by William Elder, Chief Financial Officer & General Counsel, dated October 14, 2026.
Sprouts Farmers Market said its Chief Technology Officer, James Bahrenburg, stepped down on October 12, 2026, and that the departure was not due to any disagreement with the company. He will serve as an advisor through March 31, 2027 to support an orderly transition, and remains eligible for severance under the company's executive severance plan.
James Bahrenburg stepped down as Chief Technology Officer on October 12, 2026
Departure was not the result of any disagreement with the company on operations, policies or practices
Bahrenburg will advise the company through March 31, 2027, keeping existing equity awards vesting and remaining eligible for cash bonus plan amounts
He is also eligible for severance under the Amended and Restated Executive Severance and Change in Control Plan
Longeveron Inc. disclosed that Chief Medical Officer Dr. Nataliya Agafonova informed management on October 7, 2026, of her decision to step down, effective October 14, 2026. The filing does not state a successor or the reason for her departure.
Dr. Nataliya Agafonova informed management on October 7, 2026, of her decision to step down as Chief Medical Officer.
The departure takes effect October 14, 2026.
The filing does not name a replacement or give a reason for the departure.
High Roller Technologies (ROLR) filed a Form 8-K on October 14, 2026, furnishing an updated investor presentation as Exhibit 99.1 under Regulation FD. The company said it will use the presentation in meetings with investors, analysts and other stakeholders. The filing contains no financial results, guidance or deal terms in its text.
Updated investor presentation furnished as Exhibit 99.1 and available on the company's investor relations website
Company intends to use the presentation in meetings with investors, analysts and other stakeholders
Filing is dated October 14, 2026 and signed by CFO Adam Felman
Presentation is furnished, not filed, under Section 18 of the Exchange Act
Tecogen Inc. issued a press release on October 14, 2026 featuring a customer testimonial from Cloudsmart, Inc., a Connecticut data center operator that uses the company's InVerde cogeneration system to generate its own power. The filing contains no financial results, guidance, or deal terms, so it gives shareholders no new financial figures; it does show a customer reporting lower electric bills.
Cloudsmart CEO Robyn Sullivan says the InVerde unit has run for a few months and the company cut its electric bills substantially.
Tecogen CEO Abinand Rangesh says the testimonial is a proof point for converting the company's data center pipeline to orders.
The filing gives no revenue, earnings, order, or dollar savings figures.
Five Star Bancorp announced the timing of its third quarter 2026 earnings release and webcast. The filing furnishes a press release that gives dates only and contains no financial results, so shareholders learn when results will come, not what they show.
Third quarter 2026 results (quarter ended September 30, 2026) expected after market close on Monday, October 26, 2026
Live webcast for analysts and investors set for 1:00 PM ET (10:00 AM PT) on October 27, 2026
Webcast will be archived on the company's website for 90 days
Gemini Space Station filed a prospectus supplement under its existing Form S-3 registration statement covering the potential resale of up to 7,142,857 Class A common shares by a single named investor. The filing states that the investor is not obligated to sell any of these shares, and it includes a Nevada legal opinion on the shares' validity.
Up to 7,142,857 Class A common shares, $0.001 par value, registered for potential resale by one named investor
Filed October 14, 2026 as a prospectus supplement to Form S-3, Registration No. 333-299242
Company states the registration does not mean the investor will sell any or all of the shares
SkinHealth Systems Inc. (SKIN) will combine every 20 shares of its Class A common stock into one share, effective at 12:00 a.m. ET on October 14, 2026, with trading on a split-adjusted basis on the Nasdaq Capital Market starting that day under the same ticker. The company said the split is intended to help it regain compliance with Nasdaq's $1.00 minimum bid price requirement, and that it does not change any stockholder's percentage ownership, except for cash paid in lieu of fractional shares.
Ratio: 1-for-20; outstanding shares expected to fall from approximately 130.3 million to approximately 6.5 million, based on shares outstanding as of October 7, 2026
Stockholders approved the split at a special meeting on September 22, 2026; the Board set the 1-for-20 ratio the same day
New CUSIP number 88331L306; ticker remains SKIN; convertible notes due 2028 conversion rate adjusted proportionately
The company states the split may not produce a sustained rise in share price, may reduce trading liquidity, and may not restore Nasdaq compliance
PC Connection, Inc. (CNXN) said Matthew Zafirovski joined the company as President and Chief Operating Officer effective October 12, 2026, reporting to CEO Timothy McGrath. McGrath ceased serving as President but remains Chief Executive Officer. The filing describes a new executive hire with a $700,000 base salary and a 25,000 restricted stock unit grant.
Matthew Zafirovski, 41, was CEO of Tusker from 2022 to 2026 and COO of Tusker from 2020 to 2022
Base salary of $700,000; bonus eligibility at a basic rate of 100% of base salary under the Executive Bonus Plan
Grant of 25,000 restricted stock units vesting 25% per year, starting on the first anniversary of the grant date
Severance equal to base salary for the shorter of six months or until he secures other employment, if terminated without cause, death, or disability
Kulicke and Soffa's compensation committee approved an amended and restated Incentive Compensation Plan on October 13, 2026, effective for fiscal 2027. The plan swaps Net Income and Operating Margin for Operating Profit and Gross Margin as corporate performance measures, and adds an individual goal component for Executive Leadership Team awards. For shareholders, this changes how management bonuses are tied to financial results.
Corporate performance measures changed from Net Income and Operating Margin (50% each) to Operating Profit and Gross Margin (50% each)
For fiscal 2027, Executive Leadership Team awards will be 85% based on corporate financial performance and 15% on individual goals
Business unit scorecards may be tailored by growth phase and strategic priorities, within existing governance
Plan approved October 13, 2026; filed in Form 8-K dated October 14, 2026
Bassett Furniture Industries announced a regular quarterly dividend of $0.20 per share on October 14, 2026. The dividend is payable November 27, 2026, to shareholders of record at the close of business on November 13, 2026. The filing describes a routine dividend declaration and does not include financial results or guidance.
Regular quarterly dividend of $0.20 per common share declared
Payable November 27, 2026
Record date is the close of business on November 13, 2026
TOP Financial Group Limited said it has established its global headquarters in Houston, Texas, and restructured its Board of Directors and senior leadership. The filing says the executive team's relocation to the United States is being implemented in phases, and the Board has grown from five to seven directors with new leadership appointments. The filing reports no financial results, so the changes are governance and leadership moves rather than a change in reported performance.
Board size increased from five to seven directors, under the Nominating and Corporate Governance Committee's guidance.
Jennifer Hoi Ling Tam appointed Co-Chief Executive Officer and Executive Director; Dean Huge added as Independent Director; Yuli Yan added as Executive Director.
Principal executive office established at 4201 Main Street, Suite 200, Houston, Texas 77002, following a September 4, 2026 announcement.
North American region holds 85.7% of board representation; the UK citizen accounts for the remaining 14.3%.
Alector's board approved a repricing of underwater employee stock options on October 13, 2026, resetting their exercise price to $1.87 per share, the closing price that day. The repricing includes options held by CEO Arnon Rosenthal and Chief Accounting Officer Grace Wong-Sarad, and employees who exercise before the one-year Retention Period ends must pay the original exercise price instead.
Eligible options with exercise prices above $1.87 held by current employees were repriced to $1.87 per share, effective October 13, 2026.
Approximately 4.05 million shares underlie all repriced options, which previously had exercise prices ranging from $6.48 to $33.11.
CEO Arnon Rosenthal holds options on 2,421,197 shares, and Chief Accounting Officer Grace Wong-Sarad holds options on 87,385 shares, both included in the repricing.
Exercises before the Retention Period ends, which runs up to one year, require payment of the original exercise price; expiration dates and vesting were not changed.
Nordicus Partners Corporation issued a $75,000 promissory note on October 8, 2026 to AC Nordic ApS, an entity controlled by director Torben Jensen, making it a related-party transaction. The note is payable on demand and carries interest at the lesser of 6.0% per annum or the legal maximum, and the company says the proceeds will fund working capital and general corporate purposes.
Principal amount: $75,000, issued October 8, 2026 to AC Nordic ApS
Interest rate: lesser of 6.0% per annum or the maximum permitted by law; payable on demand
Lender is wholly owned and controlled by director Torben Jensen; disinterested directors approved it with Mr. Jensen abstaining
Note was sold in a private placement under Section 4(a)(2) of the Securities Act and is unregistered
Pulse Biosciences announced on October 14, 2026, a commercial and clinical partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida, and its affiliates. The center is now treating patients with the nPulse Vybrance Percutaneous Electrode System, and the two parties will collect real-world outcomes data and work on formal clinical studies of the system for benign thyroid nodules. The filing does not disclose financial terms, so the partnership's effect on Pulse Biosciences' revenue is not quantified.
Partnership announced October 14, 2026, with the Clayman Thyroid Center and its affiliates in Tampa, Florida
The center is now treating patients with the Vybrance System as part of the company's controlled market development strategy
The center is the only site in the Tampa Bay Area offering nPulse technology for symptomatic benign thyroid nodules
Collaboration covers real-world outcomes collection and formal clinical studies; the filing gives no financial terms
Eagle Point Credit Company disclosed unaudited management estimates of its net asset value per common share as of September 30, 2026, in a range of $4.12 to $4.22. It also estimated net investment income and realized losses from investments for the quarter at $0.27 to $0.31 per weighted average common share, giving shareholders a preliminary view of the quarter's results before final figures are reported. The filing does not compare these ranges with prior periods.
Estimated net asset value per common share as of September 30, 2026: $4.12 to $4.22
Estimated net investment income and realized losses for the quarter ended September 30, 2026: $0.27 to $0.31 per weighted average common share
Figures are unaudited management estimates; the filing gives no prior-period comparison
Filed October 14, 2026 under Item 8.01 (Other Events) and signed by CFO and COO Kenneth P. Onorio
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.